New health economic study proves the value of CADScor® in coronary disease diagnostics
Press releaseMalmö, Sweden, September 7, 2021 New health economic study proves th...
Initial Dan-NICAD II results presented today at ESC
Press releaseMalmö, Sweden, August 27, 2021 Initial Dan-NICAD II results pres...
Preliminary Dan-NICAD II results to be presented at ESC
Press release Malmö, Sweden, August 23, 2021 Preliminary Dan-NICAD II results to be presented at ESC Acarix AB (publ) today ...
Acarix AB (publ) publishes Interim Report, January – June 2021
Press release Malmö, August 19, 2021 Acarix AB (publ) publishes Interim Report, January – June 2021 Continued positive t...
Acarix AB (publ) publishes Interim Report, January – March 2021
Press release Malmö, May 11, 2021 Acarix AB (publ) publishes Interim Report, January – March 2021 Prepared for an exci...
Announcement from Acarix’s annual general meeting
Announcement from Acarix's annual general meeting The annual general meeting 2021 ("AGM") of Acarix AB ("Acarix" or the "Company") was...
Acarix publishes the annual report for 2020
Press releaseMalmö, Sweden, April 20, 2021 Acarix publishes the annual report f...
Notice of Annual General Meeting in Acarix AB
Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby...
Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health
Press releaseMalmö, Sweden, April 7, 2021 Positive, long term...
A strong ending of an eventful year
Press release (MAR) Malmö, February 18, 2021 Acarix AB (publ) publishes Year-End Report 2020 A strong ending of an eventful yea...
Acarix announces the last patient included in Dan-NICAD II study
Press release Malmö, Sweden December 9, 2020 Acarix announces the last patient included in Dan-NICAD II study After the inclusi...